type here...

The Role of the State

Antitrust and Competition

Antitrust Enforcement Is Not Enough to Address Anticompetitive Conduct in Pharmaceutical Markets. Market-Oriented Legal Reform is Needed.

Alden Abbott
Federal antitrust enforcement has been robust and effective in promoting prescription drug market competition and thereby enhancing consumer welfare. Antitrust enforcement in itself, however,...
Antitrust and Competition

What’s Behind Amazon’s Demand that FTC Chair Lina Khan Recuse Herself?

Darren Bush
Amazon’s attempt to get Khan to recuse herself from any antitrust investigation into the company is not the first time that a company has...
Antitrust and Competition

Competition Problems in Prescription Drug Market

Michael Kades
Although not the sole cause of high prescription drug costs, abusive practices that distort competition contribute to the problem. Too many companies exclude competition...
Antitrust and Competition

The Profit Paradox: A New Approach to Competition and Market Power

Simcha Barkai
Jan Eeckhout’s recent book The Profit Paradox is a serious attempt to explain rising market power and its implications to a wider audience. While...
Antitrust and Competition

The Unchecked Market Power of the American Health Care System

David Ennis
Chicago Booth alumnus and retired health care consultant David W. Ennis responds to ProMarket’s recent coverage on antitrust and the US health care system....
Antitrust and Competition

Big Tech’s Tightening Grip On Internet Speech

Gregory M. Dickinson
Social media platforms have so transformed American life that many now view online speech as a right of citizenship—a right to be protected against...
Antitrust and Competition

Beefing Up Merger Enforcement by Banning Merger Remedies

Hal Singer
The unraveling of the T-Mobile/Sprint remedy continues a trend of failed merger consent decrees. One solution, proposed by two antitrust scholars, is to ban...
Antitrust and Competition

The New Challenges of Assessing Big Tech’s Impact

Michael Gofman
Big Tech firms are facing the biggest wave of antitrust legislation in their history. Academic literature reveals the complexity of possible consequences of the...
Antitrust and Competition

Why Privacy Experts Need a Place at the Antitrust Table

Cristina Caffarra
Antitrust enforcers have tended to stay narrowly “in their lane,” failing to engage with how data is collected and used by digital giants and...
Antitrust and Competition

Why the FTC Should Consider Size in Drug Mergers

Patricia M. Danzon
Large pharmaceutical firms retain their dominance through size-related advantages in three areas: contracting, marketing and selling, and financing. When reviewing pharmaceutical mergers, the Federal...
1...535455...101Page 54 of 101

Latest news

View All

The publication of the Stigler Center at The University of Chicago Booth School of Business

ProMarket is dedicated to discussing how competition tends to be subverted by special interests. The posts represent the opinions of their writers, not necessarily those of the University of Chicago, the Booth School of Business, or its faculty. For more information, please visit ProMarket Policy.